Vol 2, No 5 (October 22, 2013): Translational Lung Cancer Research (Management of early stage non-small cell lung cancer - Guest Editor: Heather Wakelee)

Preface

Management of early stage non-small cell lung cancer
Heather Wakelee
Translational Lung Cancer Research  
2013;
2
(5)
:315
.

Review Articles

Interventional pulmonology approaches in the diagnosis and treatment of early stage non small cell lung cancer
Ryu Peter Hambrook Tofts, Peter MJ Lee, Arthur Wai Sung
Translational Lung Cancer Research  
2013;
2
(5)
:316-331
.
Alternatives to surgery in early stage disease—stereotactic body radiotherapy
Meredith Elana Giuliani, Andrea Bezjak
Translational Lung Cancer Research  
2013;
2
(5)
:332-339
.
Alternative to surgery in early stage NSCLC—interventional radiologic approaches
Kyungmouk Steve Lee, Bradley B. Pua
Translational Lung Cancer Research  
2013;
2
(5)
:340-353
.
Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?
Yoshihisa Kobayashi, Tetsuya Mitsudomi
Translational Lung Cancer Research  
2013;
2
(5)
:354-363
.
Towards optimal pathologic staging of resectable non-small cell lung cancer
Raymond U. Osarogiagbon, Gail E. Darling
Translational Lung Cancer Research  
2013;
2
(5)
:364-371
.
Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures
Simona Carnio, Silvia Novello, Mauro Papotti, Marco Loiacono, Giorgio Vittorio Scaglio
Translational Lung Cancer Research  
2013;
2
(5)
:372-381
.
Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers
Philip A.J. Crosbie, Rajesh Shah, Yvonne Summers, Caroline Dive, Fiona Blackhall
Translational Lung Cancer Research  
2013;
2
(5)
:382-397
.
Neoadjuvant chemotherapy in early-stage non-small cell lung cancer
Francesc Salvà, Enriqueta Felip
Translational Lung Cancer Research  
2013;
2
(5)
:398-402
.
Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC)
Ying Liang, Heather A. Wakelee
Translational Lung Cancer Research  
2013;
2
(5)
:403-410
.

Keynote Lecture

Adjuvant molecularly targeted therapy—epidermal growth factor tyrosine kinase inhibition and beyond
Joel W. Neal, Lecia V. Sequist
Translational Lung Cancer Research  
2013;
2
(5)
:411-414
.

Review Articles

Anti-tumor immune response in early stage non small cell lung cancer (NSCLC): implications for adjuvant therapy
Charles A. Butts
Translational Lung Cancer Research  
2013;
2
(5)
:415-422
.
Post-operative radiation therapy
Amaury Paumier, Cécile Le Péchoux
Translational Lung Cancer Research  
2013;
2
(5)
:423-432
.

Disclosure:

The focused issue “Management of early stage non-small cell lung cancer - Guest Editor” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Heather Wakelee served as the unpaid Guest Editor for the focused issue.